These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29084869)

  • 1. Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies.
    Berzero G; Karantoni E; Dehais C; Ducray F; Thomas L; Picard G; Rogemond V; Candelier G; Camdessanché JP; Antoine JC; De Seze J; Liou-Schischmanoff A; Honnorat J; Delattre JY; Psimaras D
    J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):789-792. PubMed ID: 29084869
    [No Abstract]   [Full Text] [Related]  

  • 2. Early-onset immunotherapy by intravenous immunoglobulin and corticosteroids in well characterized onconeural-antibody-positive paraneoplastic neurological syndrome.
    Honnorat J
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):127-9. PubMed ID: 25546790
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of idiopathic opsoclonus-myoclonus syndrome with intravenous immunoglobulin.
    Unal A; Sumer MM; Atasoy HT; Atasoy N
    Neurol India; 2004 Dec; 52(4):520-1. PubMed ID: 15626860
    [No Abstract]   [Full Text] [Related]  

  • 4. [Paraneoplastic neurological syndromes].
    Antoine JC; Camdessanché JP
    Presse Med; 2007 Oct; 36(10 Pt 2):1418-26. PubMed ID: 17399944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal synthesis of onconeural antibodies in patients with paraneoplastic syndromes.
    Corsini E; Gaviani P; Chiapparini L; Lazzaroni M; Ciusani E; Bisogno R; Silvani A; Salmaggi A; Bernardi G
    J Neuroimmunol; 2016 Jan; 290():119-22. PubMed ID: 26711581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
    Raspotnig M; Vedeler C; Storstein A
    J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders.
    Blaes F; Strittmatter M; Merkelbach S; Jost V; Klotz M; Schimrigk K; Hamann GF
    J Neurol; 1999 Apr; 246(4):299-303. PubMed ID: 10367699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor neuron disease of paraneoplastic origin: a rare but treatable condition.
    Mélé N; Berzero G; Maisonobe T; Salachas F; Nicolas G; Weiss N; Beaudonnet G; Ducray F; Psimaras D; Lenglet T
    J Neurol; 2018 Jul; 265(7):1590-1599. PubMed ID: 29725842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed onset of a second paraneoplastic neurological syndrome in eight patients.
    Ducray F; Graus F; Vigliani MC; Antoine JC; Rogemond V; Saiz A; Honnorat J
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):937-9. PubMed ID: 20562403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.
    Bataller L; Graus F; Saiz A; Vilchez JJ;
    Brain; 2001 Feb; 124(Pt 2):437-43. PubMed ID: 11157570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of patients with paraneoplastic myelopathy.
    Liu Z; Jiao L; Qiu Z; Da Y; Tang Y; Lin Y; Li D; Huang J; Kang X; Dong H
    J Neuroimmunol; 2019 May; 330():136-142. PubMed ID: 30878696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulins in paraneoplastic brainstem encephalitis with anti-Ri antibodies.
    Fumal A; Jobe J; Pepin JL; Delvaux V; Senterre JM; Bonaventure S; de Noordhout AM
    J Neurol; 2006 Oct; 253(10):1360-1. PubMed ID: 17006632
    [No Abstract]   [Full Text] [Related]  

  • 14. A myxoid chondrosarcoma associated with an anti-Hu-positive paraneoplastic encephalomyelitis.
    Hoosien M; Vredenburgh J; Lanfranco J; Ochoa R; Robinson P; Martinez R; Singer C; Silva O
    J Neurooncol; 2011 Jan; 101(1):135-9. PubMed ID: 20443130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
    Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
    J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parainfectious opsoclonus-myoclonus syndrome: high dose intravenous immunoglobulins are effective.
    Glatz K; Meinck HM; Wildemann B
    J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):279-80. PubMed ID: 12531974
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of paraneoplastic neurological syndrome].
    Inuzuka T
    No To Shinkei; 2000 Dec; 52(12):1057-62. PubMed ID: 11193537
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
    Uchuya M; Graus F; Vega F; Reñé R; Delattre JY
    J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):388-92. PubMed ID: 8774401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positivity of serum "classical" onconeural antibodies in a series of 2063 consecutive patients with suspicion of paraneoplastic neurological syndrome.
    Gromadzka G; Karlińska AG; Łysiak Z; Błażejewska-Hyżorek B; Litwin T; Członkowska A
    J Neuroimmunol; 2013 Jun; 259(1-2):75-80. PubMed ID: 23642452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paraneoplastic neurological syndromes].
    Storstein A; Vedeler CA
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):524-8. PubMed ID: 19282889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.